Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactHepatitis C virus proteinsHepatitis C virus and neurological damageHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective TherapyHepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy optionsHepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environmentPathophysiological Relationship between Infections and Systemic VasculitisDirect effects of hepatitis C virus on the lymphoid cellsAutoimmunity and infection in Sjögren's syndromeAltered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infectionAnalysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated ControlsHepatitis C virus and lymphomaClonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinInduction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunityB-cell clonality in the liver of hepatitis C virus-infected patientsHepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapyCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesVasculitic syndromes in hepatitis C virus: A review."Negative vaccination" by specific CD4 T cell tolerisation enhances virus-specific protective antibody responsesChronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.Immunological alterations in hepatitis C virus infection.Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.Hepatitis C virus associated glomerulopathies.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagementAntibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.Immune control and failure in HCV infection--tipping the balance.GBV-C infection and risk of NHL among U.S. adults.EBV, HCMV, HHV6, and HHV7 screening in bone marrow samples from children with acute lymphoblastic leukemia.Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins.CD100 up-regulation induced by interferon-α on B cells is related to hepatitis C virus infection.Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection.Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosisInterferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infectionTemporal variations in the hepatitis C virus intrahost population during chronic infection.
P2860
Q22299128-C69F5EA9-3771-4F95-B06A-4CE37380A020Q24563969-328C13B4-F54B-4A5F-9FB9-DE18715A2A83Q26748575-D39CF71C-72D4-4EF9-AB8C-CE187820B01FQ26750997-345D4F5D-931E-4912-B4DE-22D9A5BD0267Q26770344-315F2B3E-6F34-4385-91D4-1B3C83DE5F05Q26775007-0935D551-54B0-4B78-9B48-E21EF85B667CQ26775018-239111D4-078E-492E-9725-16F726D00420Q26799915-A2926B60-CC2D-4CEB-A527-EB12D4874FF6Q26992142-1F89EE2D-3C1E-47F7-8D55-0B3D88FEA870Q27026174-395F8556-5434-4EB1-9A43-BD814F18DE5CQ27478138-603AA8BE-12A9-4C4C-8B5C-1BCBE139765AQ27480341-DF22D97A-B10C-4D72-B8E9-09F59352EF12Q27482007-682F03D0-24E7-43AA-B31F-04C8C14D52EFQ27485227-B097FF2E-164A-4BEB-9552-16F6C6DA6665Q27486411-C9C7543E-072C-4060-835B-7B3678207B7BQ27486582-4AC1F561-B57C-474A-A1C0-8C35F58708F2Q27487927-D48D0874-176F-402E-B1A0-D1978F8747FAQ27488318-EF147D4A-DEEF-4230-B90A-6CFCD03C1C0EQ27488413-14D0226C-90E8-4A80-970E-1D1F54796EBCQ27488883-D1B6A8ED-56ED-4147-B005-D1F4C686FC0CQ30238653-EAF51348-8265-473B-89A2-26A0AEFF2ABCQ33305432-0E68E8E3-99C6-4E60-A9B0-93C136871411Q33378075-5CD8F39B-FD08-478D-A0F5-B4A5AB108D75Q33412382-B1C1BBF5-DFD1-4C21-A9AA-EE72A20DE523Q33760703-86E517DB-1105-487F-AAFF-A9ECDA178110Q33801278-46DFE9A7-C60D-44FD-801D-F891DEBC29C9Q33883727-8D229103-78C2-48E3-9860-5CD13FC04491Q34043387-B00F9046-4BF0-4B68-9E7C-3BDEF4F53D1DQ34178628-F50C9750-6BA3-4690-A15A-3FDF44B5D14CQ34287698-2424B862-CB3B-4A3A-8DBE-E00BA07DF8E7Q34306768-4F53FCBA-580E-4E5D-BC08-144A54C30C69Q34450690-FC33AF5D-2010-42B5-8145-74E29CA29CAAQ34524664-C841311C-D984-44C4-BA3D-D5CFB4144379Q34599645-F976616B-EDCA-4B80-877F-02EEE7574035Q34669793-0BC737D6-7AC2-49DE-9472-1D7B80097EA8Q34756691-77A33808-9DB6-4774-B1BE-77E51C258C6FQ34808755-B9381C21-C050-4F66-8EFE-DAC07FEB9F2AQ34825837-852F6E27-C79E-4E93-997A-2A60C4F5C582Q35076717-5AEEA436-EFD0-4C47-8910-857854514806Q35077466-C19EC29F-6946-403E-B348-8B06BACC548A
P2860
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Activation of naive B lymphocy ...... ociated B lymphocyte disorders
@nl
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@ast
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@en
type
label
Activation of naive B lymphocy ...... ociated B lymphocyte disorders
@nl
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@ast
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@en
prefLabel
Activation of naive B lymphocy ...... ociated B lymphocyte disorders
@nl
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@ast
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@en
P2093
P2860
P356
P1476
Activation of naïve B lymphocy ...... ciated B lymphocyte disorders.
@en
P2093
Consuelo Comar
Domenico Rosa
Ennio De Gregorio
Francesca Zorat
Gabriele Pozzato
Giulietta Saletti
Michael Houghton
Sandra Nuti
Sergio Abrignani
P2860
P304
18544-18549
P356
10.1073/PNAS.0509402102
P407
P577
2005-12-09T00:00:00Z